SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-061104
Filing Date
2024-05-16
Accepted
2024-05-16 16:23:40
Documents
2
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1591
2 EX-24 virx-ex24.htm EX-24 9225
  Complete submission text file 0000950170-24-061104.txt   12491
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O THERAVANCE, INC. 951 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Faerm Michael E. (Reporting) CIK: 0001647141 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 24955957